• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞与脑癌。

Stem cells and brain cancer.

作者信息

Fomchenko Elena I, Holland Eric C

机构信息

Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.

出版信息

Exp Cell Res. 2005 Jun 10;306(2):323-9. doi: 10.1016/j.yexcr.2005.03.007. Epub 2005 Apr 14.

DOI:10.1016/j.yexcr.2005.03.007
PMID:15925587
Abstract

One of the most devastating CNS pathologies is brain cancer. The undifferentiated character of brain tumor cells and recent reports of cancer stem cells prompt questions regarding the involvement of normal stem/progenitor cells in brain tumor biology, their potential contribution to the tumor itself, and whether they are the cause or the consequence of tumor initiation and progression. The cancer stem cell model proposes a clonally derived brain tumor arising from a cancer stem cell. This tumor cell-of-origin originates from a stem/progenitor or more differentiated cell via acquisition of oncogenic mutations that dysregulate or allow reacquisition of self-renewal mechanisms. The tumor cells differentiate unidirectionally from the cancer stem cell in a way parallel to normal development. However, several properties of brain tumors add complexity to this model. For example, the apparent lineage and differentiation status of tumor cells are significantly affected by signaling abnormalities that are causally related to formation of the tumor. In addition, these tumors recruit normal CNS stem and progenitor cells to the tumor mass leading to the possibility of a heterogeneous and polyclonal cell population. It is likely that a complete description of the role of stem cells in brain tumors will be more complex than our current models.

摘要

最具毁灭性的中枢神经系统病理学疾病之一是脑癌。脑肿瘤细胞的未分化特性以及近期有关癌症干细胞的报道引发了诸多问题,涉及正常干细胞/祖细胞在脑肿瘤生物学中的作用、它们对肿瘤本身的潜在贡献,以及它们是肿瘤起始和进展的原因还是结果。癌症干细胞模型提出,克隆起源的脑肿瘤源自癌症干细胞。这种肿瘤起源细胞通过获得致癌突变而从干细胞/祖细胞或更分化的细胞产生,这些突变会失调或使自我更新机制重新获得。肿瘤细胞从癌症干细胞单向分化,其方式与正常发育平行。然而,脑肿瘤的几个特性使该模型变得复杂。例如,肿瘤细胞的明显谱系和分化状态会受到与肿瘤形成有因果关系的信号异常的显著影响。此外,这些肿瘤会将正常的中枢神经系统干细胞和祖细胞募集到肿瘤块中,导致细胞群体可能具有异质性和多克隆性。干细胞在脑肿瘤中的作用的完整描述可能比我们目前的模型更为复杂。

相似文献

1
Stem cells and brain cancer.干细胞与脑癌。
Exp Cell Res. 2005 Jun 10;306(2):323-9. doi: 10.1016/j.yexcr.2005.03.007. Epub 2005 Apr 14.
2
Cancer stem cells in nervous system tumors.神经系统肿瘤中的癌症干细胞。
Oncogene. 2004 Sep 20;23(43):7267-73. doi: 10.1038/sj.onc.1207946.
3
Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers.干细胞分化的成熟停滞是畸胎癌和上皮癌细胞起源的常见途径。
Lab Invest. 1994 Jan;70(1):6-22.
4
Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.在胶质母细胞瘤的人类模型中,人类成年非致瘤性干细胞向癌症干细胞的自发转化是由基因组不稳定性驱动的。
Stem Cells. 2007 Jun;25(6):1478-89. doi: 10.1634/stemcells.2006-0585. Epub 2007 Mar 1.
5
Cancer stem cells.癌症干细胞
Neoplasma. 2005;52(6):435-40.
6
Origin of cancer stem cells: the role of self-renewal and differentiation.癌症干细胞的起源:自我更新与分化的作用
Ann Surg Oncol. 2008 Feb;15(2):407-14. doi: 10.1245/s10434-007-9695-y. Epub 2007 Nov 28.
7
Cancer stem cell hypothesis in thyroid cancer.甲状腺癌中的癌干细胞假说
Pathol Int. 2006 Sep;56(9):485-9. doi: 10.1111/j.1440-1827.2006.01995.x.
8
Cancer stem cells in solid tumors.实体瘤中的癌症干细胞。
Curr Opin Biotechnol. 2007 Oct;18(5):460-6. doi: 10.1016/j.copbio.2007.10.007.
9
Recurrence cancer stem cells--made by cell fusion?复发性癌症干细胞——由细胞融合产生?
Med Hypotheses. 2009 Oct;73(4):542-7. doi: 10.1016/j.mehy.2009.05.044. Epub 2009 Jun 28.
10
[Cancer initiating cell theory: popularity and controversies].[癌症起始细胞理论:流行与争议]
Ai Zheng. 2006 Jun;25(6):779-84.

引用本文的文献

1
Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies.解析胶质母细胞瘤微环境:开辟全新治疗策略的第一步。
Genes (Basel). 2021 Mar 20;12(3):445. doi: 10.3390/genes12030445.
2
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma.与单甲基澳瑞他汀E一样,配置有抗降钙素受体抗体的地辛-30或凝胶onin在源自胶质母细胞瘤的高级别胶质瘤细胞系中体外效力存在差异。
Cancer Immunol Immunother. 2017 Sep;66(9):1217-1228. doi: 10.1007/s00262-017-2013-z. Epub 2017 May 13.
3
Implications of irradiating the subventricular zone stem cell niche.
照射脑室下区干细胞龛的影响。
Stem Cell Res. 2016 Mar;16(2):387-96. doi: 10.1016/j.scr.2016.02.031. Epub 2016 Feb 17.
4
EGF as a New Therapeutic Target for Medulloblastoma Metastasis.表皮生长因子作为髓母细胞瘤转移的新治疗靶点
Cell Mol Bioeng. 2015 Dec;8(4):553-565. doi: 10.1007/s12195-015-0395-6. Epub 2015 Jun 4.
5
Glutamine synthetase functions as a negative growth regulator in glioma.谷氨酰胺合成酶在神经胶质瘤中作为一种负生长调节剂发挥作用。
J Neurooncol. 2013 Aug;114(1):59-69. doi: 10.1007/s11060-013-1168-5. Epub 2013 Jun 19.
6
Gene analysis and dynamics of tumor stem cells in human glioblastoma cells after radiation.人胶质母细胞瘤细胞经放射治疗后肿瘤干细胞的基因分析和动力学。
Hum Cell. 2013 Jun;26(2):73-9. doi: 10.1007/s13577-013-0060-0. Epub 2013 Mar 9.
7
Molecular imaging of stem cell therapy in brain tumors: a step towards personalized medicine.脑肿瘤干细胞治疗的分子成像:迈向个性化医疗的一步。
Arch Med Sci. 2012 Sep 8;8(4):601-5. doi: 10.5114/aoms.2012.30282.
8
Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma.促进神经胶质瘤中少突胶质前体细胞样细胞分化或静止的候选途径。
Cancer Res. 2012 Sep 15;72(18):4856-68. doi: 10.1158/0008-5472.CAN-11-2632. Epub 2012 Aug 3.
9
Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.脑胶质瘤肿瘤干细胞的化疗耐药性——比预期的要复杂得多。
Mol Cancer. 2011 Oct 11;10:128. doi: 10.1186/1476-4598-10-128.
10
p53 in the CNS: Perspectives on Development, Stem Cells, and Cancer.中枢神经系统中的p53:关于发育、干细胞和癌症的观点
Genes Cancer. 2011 Apr;2(4):431-42. doi: 10.1177/1947601911409736.